Results 101 to 110 of about 136 (117)
Revista Portuguesa De Pneumologia, 2008 AbstractUntil 2004, docetaxel in monotherapy was the standard for second-line treatment of non-small cell lung cancer (NSCLC). Pemetrexed (P) has shown similar activity in this setting with a better adverse event profile. In Portugal, it was introduced in October of 2004.We have carried out a retrospective analysis of patients (pts) who received P for ...
J Cunha, E Teixeira
exaly +3 more sources
Carcinoma do pulmão de pequenas células – Estado da arte e perspectivas futuras
Revista Portuguesa De Pneumologia, 2007 AbstractLung cancer is the leading cause of cancer related death in Portugal. Almost 3500 Portuguese are expected to be diagnosed with lung cancer in 2006; approximately 20% will have small cell lung cancer (SCLC). At presentation, 25% to 30% of patients will have local or regional disease, classified as limited stage disease.
Barata,Fernando J, Costa,Ana Filipa
exaly +6 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Oral cavity and oropharyngeal squamous cell carcinoma—an update
Ca-A Cancer Journal for Clinicians, 2015Angela C Chi, Terry A Day
exaly
Treatment of renal cell carcinoma: Current status and future directions
Ca-A Cancer Journal for Clinicians, 2017Pedro Coelho Barata
exaly
Quimioterapia citostática do carcinoma pulmonar de pequenas células
Revista Portuguesa De Pneumologia, 1996Renato Sotto-Mayor
exaly